I am pleased to share the final program for Fierce JPM Week 2021. To view this email as a web page,
click here | Dear E, I am pleased to share the final program for Fierce JPM Week 2021 – a three-day virtual event bringing together top biopharma and healthcare leaders to explore the latest issues, from COVID-19 to the post-pandemic future. Through CEO interviews, panel discussions, and company presentations, this event will provide attendees with an in depth perspective straight from the experts. With a strong focus on networking, this year's virtual platform will allow you to facilitate one-to-one video meetings and group chats with speakers, partners, and attendees. | |
|
|
| Panel: In-development COVID-19 therapeutics Executive Interview: Sean Bohen, CEO, Olema Oncology Executive Interview: George Scangos, Ph.D., CEO, Vir Panel: "Second-wave" COVID-19 vaccines Executive Interview: Stephane Bancel, CEO, Moderna Executive Interview: Samit Hirawat, Chief Medical Officer, Bristol Meyers Squibb Panel: The last mile: How will a COVID-19 vaccine make it from plant to patients? Executive Interview: Vivian Lee, President of Health Platforms, Verily Life Sciences Executive Interview: Joe Jimenez, Co-Founder, Aditum Bio | |
|
|
| Thank You to Our Sponsors | |
|
|
| You are currently subscribed as [email protected] If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe. Refer to our Privacy Policy. Fierce LifeSciences is a division of Questex LLC. 685 3rd Ave 21st Floor New York, NY 10017 © 2020 Questex LLC. All Rights Reserved. Reproduction in whole or in part is prohibited without written permission. |
| |
|
|
|
|
|